持久性左心室辅助装置植入术后早期卒中:STS Intermacs 国家数据库分析
基于 STS Intermacs 数据库 6950 例植入全磁悬浮离心式 LVAD 患者,5.9% 发生卒中,其中 50% 在术后 7 天内,70% 的早期卒中发生在术后 0-2 天。多因素分析显示高龄、白种人、术前临时 MCS 桥接及未清除的左心房血栓与早期卒中相关。
要点
- LVAD 植入后早期卒中高发,半数卒中在术后 7 天内,其中 70% 集中于术后 0-2 天。
- 术前临时 MCS 桥接显著增加早期卒中风险,双设备联合风险最高。
- 未清除的左心房血栓与早期卒中强相关,为可干预的术中因素。
核心结论
- LVAD 植入后 7 天内卒中比例显著,尤其术后 2 天内高发。
- 除术前因素外,可干预的术中因素与早期卒中相关,为风险控制提供机会。
研究设计与样本
- 回顾性队列研究,查询 STS Intermacs 国家数据库。
- 纳入 2020 年 11 月 25 日至 2023 年 6 月 30 日植入全磁悬浮离心式 LVAD 的患者,共 6950 例。
- 采用多因素 logistic 回归模型计算调整比值比(OR)。
主要发现
- 中位随访 11 个月,5.9%(413/6950)发生卒中,其中 50%(205/413)在术后 7 天内。
- 术后 0-7 天卒中中,70%(144/205)发生在术后 0-2 天。
- 多因素分析显示高龄(70 vs 50;OR 1.4,p=0.0129)与早期卒中相关。
- 白种人(OR 1.5,p=0.0078)与早期卒中相关。
- 术前临时 MCS 桥接与早期卒中相关:临时 LVAD 仅 OR 1.6,ECMO 仅 OR 1.7,两者联合 OR 3.3(p=0.0001)。
临床怎么用
- 对 LVAD 候选患者应评估术前临时 MCS 使用及左心房血栓,以识别早期卒中高危人群。
- 术中应争取清除左心房血栓,作为潜在可干预的风险控制措施。
- 术后前 2 天应加强神经功能监测,警惕早期卒中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke remains a devastating complication of durable left ventricular assist device (LVAD) therapy. This study evaluated the incidence and risk factors for early stroke within 7 days following LVAD implantation investigating both traditional pre-implant and new intraoperative variables collected by The Society of Thoracic Surgeons (STS) Intermacs National Database. METHODS: STS Intermacs was queried for patients undergoing implantation of a fully magnetically levitated centrifugal LVAD between November 25, 2020 and June 30, 2023. STS Intermacs stroke definitions were used to identify patients who suffered a stroke within the first 7 postoperative days (POD). A multivariable logistic regression model was created to generate adjusted odd ratios (OR) for variables associated with early stroke. RESULTS: Among 6,950 patients in the study cohort, 5.9% (413/6950) developed a stroke after a median follow-up of 11 months, with 50% (205/413) of strokes occurring within 7 days after LVAD implantation. Of the strokes occurring during POD 0-7, 70% (144/205) occurred on POD 0-2. By multivariable analysis, the following factors were associated with early stroke: older age (70 vs 50; OR 1.4, p = 0.0129), white race (OR 1.5, p = 0.0078), pre-implant temporary mechanical circulatory support (MCS) bridge (temporary LVAD only: OR 1.6, extracorporeal membrane oxygenation [ECMO] only: OR 1.7, combination of both devices: OR 3.3; p = 0.0001) and presence of an unremoved left atrial clot (OR 8.0, p < 0.0001). CONCLUSIONS: A significant proportion of strokes occur within the first 7 days following LVAD implantation, particularly within the first 2 days. In addition to pre-implant variables, we identified modifiable intraoperative factors associated with stroke that provide an opportunity for further risk mitigation and improvement in quality of care.
引用
- Molina EJ, Goldstein D, Cantor RS, et al. Early stroke following durable left ventricular assist device (LVAD) implantation: An analysis of the Society of Thoracic Surgeons Intermacs National Database. J Heart Lung Transplant. 2024. PMID: 39389330. doi:10.1016/j.healun.2024.09.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。